Complete the U.S. regulatory filing for aducanumab
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 22 Apr 2020
- Due
- 30 Sep 2020
- Delivered
- July 2020
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Biogen expects to complete the U.S. filing in the third quarter of 2020.”
What we found
Evidence strength A What the grades mean
Biogen completed the submission of the Biologics License Application (BLA) for aducanumab to the FDA in July 2020, which falls within the third quarter of 2020.
-
A Biogen 10-Q filed 2020-10-21
“In July 2020 we completed the submission of a BLA to the FDA for the approval of aducanumab.” ✓ confirmed on the page
Market reaction: the shares moved -1.5% against the S&P 500 over the three sessions around the disclosure (20 Oct 2020 to 23 Oct 2020). What this measures
Checked 8 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory other
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- U.S. regulatory filing for aducanumab
- Where
- U.S.
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Biogen? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-BIIB-005338 · Corrections policy